AstraZeneca is seeking a Vice President of Radioconjugate Development to lead the strategic development of novel radioconjugates aimed at enhancing cancer treatment. The ideal candidate will have extensive experience in oncology drug development and strong leadership skills to navigate a complex, matrixed environment.
Base: $336,785.60 - $505,178.40; Bonus/Equity: short-term incentive bonus and equity-based long-term incentive program; Benefits: 401(k), paid vacation, holidays, leaves, health benefits
Must-have
Nice-to-have
Not specified